Resmed (RSMDF) Restructuring Costs (2015 - 2025)

Resmed (RSMDF) has reported Restructuring Costs for 9 consecutive years, with $5.9 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Restructuring Costs changed N/A year-over-year to $5.9 million; the trailing twelve-month figure through Jun 2026 stood at $21.7 million (changed N/A YoY), and the FY2026 full-year result was $21.7 million, changed N/A from the prior year.
• Restructuring Costs retreated to $5.9 million in Q4 2025 per RSMDF's latest filing, from $15.8 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $64.2 million in Q4 2023 and bottomed at $1.8 million in Q2 2023.
• Historically, Restructuring Costs has averaged $16.3 million across 3 years, with a median of $7.2 million in 2022.
• The widest YoY moves for Restructuring Costs: up 663.53% in 2023, down 5.68% in 2023.
• Over 3 years, Restructuring Costs stood at $8.4 million in 2022, then jumped by 663.53% to $64.2 million in 2023, then tumbled by 90.76% to $5.9 million in 2025.
• According to Business Quant data, Restructuring Costs over the past three periods registered $5.9 million, $15.8 million, and $64.2 million for Q4 2025, Q3 2025, and Q4 2023 respectively.